Found: 17
Select item for more details and to access through your institution.
Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 1, p. 111, doi. 10.1093/ndt/gfaa011
- By:
- Publication type:
- Article
Dipyridamole Dilates Large Cerebral Arteries Concomitant to Headache Induction in Healthy Subjects.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2000, v. 20, n. 9, p. 1372, doi. 10.1097/00004647-200009000-00012
- By:
- Publication type:
- Article
Sympathetic block by metal clips may be a reversible operation.
- Published in:
- Interactive Cardiovascular & Thoracic Surgery, 2014, v. 19, n. 6, p. 908, doi. 10.1093/icvts/ivu311
- By:
- Publication type:
- Article
Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease.
- Published in:
- Drug Design, Development & Therapy, 2012, v. 6, p. 43, doi. 10.2147/DDDT.S30015
- By:
- Publication type:
- Article
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors: a randomized double-blind placebo-controlled clinical trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 4, p. 402, doi. 10.1002/phar.1729
- By:
- Publication type:
- Article
Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. E11, doi. 10.1002/ajh.26015
- By:
- Publication type:
- Article
A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. E276, doi. 10.1002/ajh.25920
- By:
- Publication type:
- Article
A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 1007, doi. 10.1002/ajh.25564
- By:
- Publication type:
- Article
Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. E148, doi. 10.1002/ajh.25094
- By:
- Publication type:
- Article
A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 3, p. 286, doi. 10.1002/ajh.24633
- By:
- Publication type:
- Article
A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia.
- Published in:
- Nephrology Dialysis Transplantation, 2016, v. 31, n. 4, p. 646, doi. 10.1093/ndt/gfv293
- By:
- Publication type:
- Article
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.
- Published in:
- Nephrology Dialysis Transplantation, 2015, v. 30, n. 9, p. 1577, doi. 10.1093/ndt/gfv096
- By:
- Publication type:
- Article
Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery.
- Published in:
- Obesity Surgery, 2022, v. 32, n. 3, p. 810, doi. 10.1007/s11695-021-05858-0
- By:
- Publication type:
- Article
A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED).
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 12, p. 1877, doi. 10.1038/ajg.2013.335
- By:
- Publication type:
- Article
Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.
- Published in:
- Journal of Nephrology (JNonline), 2011, v. 24, n. 5, p. 589, doi. 10.5301/JN.2010.6248
- By:
- Publication type:
- Article